Clinical Cirrhosis Dilemmas: Survey of Practice from the 7th International Coagulation in Liver Disease Conference

Jonathan G. Stine, Nicolas M. Intagliata, Neeral L. Shah, Ton Lisman, Francesco Violi, Stephen H. Caldwell, Curtis K. Argo

Research output: Contribution to journalArticle

Abstract

Introduction and Aim: Hemostatic disorders in chronic liver disease and cirrhosis show continued expansion of research efforts. However, clinical decision making is often practiced on an individual patient level as consensus guidelines are lacking. We aimed to better assess individual day-to-day clinical practice through gauging clinicians’ responses to common clinical scenarios. Materials and Methods: A series of ten clinical scenarios (seven procedural coagulation and three thrombosis management) were posed to conference attendees utilizing real-time polling software (Poll Everywhere). Responses were binomial and were submitted as “Agree” or “Disagree.” Results were displayed real time following a standardized response period and an open-forum discussion ensued between conference faculty and attendees following response submission. Results: Twenty conference attendees participated in the clinical scenario plenary session. In general, agreement rates were high. All but one of the ten clinical scenarios had ≥ 70% agreement. Agreement was based both on procedural risk, with greatest agreement seen for low-risk procedures (80–93%), and on peri-procedural coagulation parameters of platelet count and fibrinogen level where > 50,000μ/L and 120 mg/dL were the most agreed upon thresholds, respectively. 75–95% agreement was reached when surveying the need for anticoagulation for mesenteric vein thrombosis in liver transplant candidates; slightly less (71%) agreement was found when deciding to proceed with anticoagulation in non-liver transplant candidates with mesenteric vein thrombosis. Conclusions: While large-scale, methodologically rigorous randomized controlled trials are lacking to guide clinical decision making in patients with coagulation disorders and chronic liver disease, consensus expert opinion regarding mitigating peri-procedural bleeding risk and treatment of thrombosis appears consistent and strong.

Original languageEnglish (US)
JournalDigestive Diseases and Sciences
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Liver Diseases
Thrombosis
Fibrosis
Mesenteric Veins
Chronic Disease
Hemostatic Disorders
Transplants
Expert Testimony
Platelet Count
Liver Cirrhosis
Fibrinogen
Software
Randomized Controlled Trials
Guidelines
Hemorrhage
Surveys and Questionnaires
Liver
Research
Clinical Decision-Making
Therapeutics

All Science Journal Classification (ASJC) codes

  • Physiology
  • Gastroenterology

Cite this

Stine, Jonathan G. ; Intagliata, Nicolas M. ; Shah, Neeral L. ; Lisman, Ton ; Violi, Francesco ; Caldwell, Stephen H. ; Argo, Curtis K. / Clinical Cirrhosis Dilemmas : Survey of Practice from the 7th International Coagulation in Liver Disease Conference. In: Digestive Diseases and Sciences. 2019.
@article{ea45320d549d46bea405f0ea9c316534,
title = "Clinical Cirrhosis Dilemmas: Survey of Practice from the 7th International Coagulation in Liver Disease Conference",
abstract = "Introduction and Aim: Hemostatic disorders in chronic liver disease and cirrhosis show continued expansion of research efforts. However, clinical decision making is often practiced on an individual patient level as consensus guidelines are lacking. We aimed to better assess individual day-to-day clinical practice through gauging clinicians’ responses to common clinical scenarios. Materials and Methods: A series of ten clinical scenarios (seven procedural coagulation and three thrombosis management) were posed to conference attendees utilizing real-time polling software (Poll Everywhere). Responses were binomial and were submitted as “Agree” or “Disagree.” Results were displayed real time following a standardized response period and an open-forum discussion ensued between conference faculty and attendees following response submission. Results: Twenty conference attendees participated in the clinical scenario plenary session. In general, agreement rates were high. All but one of the ten clinical scenarios had ≥ 70{\%} agreement. Agreement was based both on procedural risk, with greatest agreement seen for low-risk procedures (80–93{\%}), and on peri-procedural coagulation parameters of platelet count and fibrinogen level where > 50,000μ/L and 120 mg/dL were the most agreed upon thresholds, respectively. 75–95{\%} agreement was reached when surveying the need for anticoagulation for mesenteric vein thrombosis in liver transplant candidates; slightly less (71{\%}) agreement was found when deciding to proceed with anticoagulation in non-liver transplant candidates with mesenteric vein thrombosis. Conclusions: While large-scale, methodologically rigorous randomized controlled trials are lacking to guide clinical decision making in patients with coagulation disorders and chronic liver disease, consensus expert opinion regarding mitigating peri-procedural bleeding risk and treatment of thrombosis appears consistent and strong.",
author = "Stine, {Jonathan G.} and Intagliata, {Nicolas M.} and Shah, {Neeral L.} and Ton Lisman and Francesco Violi and Caldwell, {Stephen H.} and Argo, {Curtis K.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s10620-019-05884-0",
language = "English (US)",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Kluwer Academic Publishers-Plenum Publishers",

}

Clinical Cirrhosis Dilemmas : Survey of Practice from the 7th International Coagulation in Liver Disease Conference. / Stine, Jonathan G.; Intagliata, Nicolas M.; Shah, Neeral L.; Lisman, Ton; Violi, Francesco; Caldwell, Stephen H.; Argo, Curtis K.

In: Digestive Diseases and Sciences, 01.01.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical Cirrhosis Dilemmas

T2 - Survey of Practice from the 7th International Coagulation in Liver Disease Conference

AU - Stine, Jonathan G.

AU - Intagliata, Nicolas M.

AU - Shah, Neeral L.

AU - Lisman, Ton

AU - Violi, Francesco

AU - Caldwell, Stephen H.

AU - Argo, Curtis K.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Introduction and Aim: Hemostatic disorders in chronic liver disease and cirrhosis show continued expansion of research efforts. However, clinical decision making is often practiced on an individual patient level as consensus guidelines are lacking. We aimed to better assess individual day-to-day clinical practice through gauging clinicians’ responses to common clinical scenarios. Materials and Methods: A series of ten clinical scenarios (seven procedural coagulation and three thrombosis management) were posed to conference attendees utilizing real-time polling software (Poll Everywhere). Responses were binomial and were submitted as “Agree” or “Disagree.” Results were displayed real time following a standardized response period and an open-forum discussion ensued between conference faculty and attendees following response submission. Results: Twenty conference attendees participated in the clinical scenario plenary session. In general, agreement rates were high. All but one of the ten clinical scenarios had ≥ 70% agreement. Agreement was based both on procedural risk, with greatest agreement seen for low-risk procedures (80–93%), and on peri-procedural coagulation parameters of platelet count and fibrinogen level where > 50,000μ/L and 120 mg/dL were the most agreed upon thresholds, respectively. 75–95% agreement was reached when surveying the need for anticoagulation for mesenteric vein thrombosis in liver transplant candidates; slightly less (71%) agreement was found when deciding to proceed with anticoagulation in non-liver transplant candidates with mesenteric vein thrombosis. Conclusions: While large-scale, methodologically rigorous randomized controlled trials are lacking to guide clinical decision making in patients with coagulation disorders and chronic liver disease, consensus expert opinion regarding mitigating peri-procedural bleeding risk and treatment of thrombosis appears consistent and strong.

AB - Introduction and Aim: Hemostatic disorders in chronic liver disease and cirrhosis show continued expansion of research efforts. However, clinical decision making is often practiced on an individual patient level as consensus guidelines are lacking. We aimed to better assess individual day-to-day clinical practice through gauging clinicians’ responses to common clinical scenarios. Materials and Methods: A series of ten clinical scenarios (seven procedural coagulation and three thrombosis management) were posed to conference attendees utilizing real-time polling software (Poll Everywhere). Responses were binomial and were submitted as “Agree” or “Disagree.” Results were displayed real time following a standardized response period and an open-forum discussion ensued between conference faculty and attendees following response submission. Results: Twenty conference attendees participated in the clinical scenario plenary session. In general, agreement rates were high. All but one of the ten clinical scenarios had ≥ 70% agreement. Agreement was based both on procedural risk, with greatest agreement seen for low-risk procedures (80–93%), and on peri-procedural coagulation parameters of platelet count and fibrinogen level where > 50,000μ/L and 120 mg/dL were the most agreed upon thresholds, respectively. 75–95% agreement was reached when surveying the need for anticoagulation for mesenteric vein thrombosis in liver transplant candidates; slightly less (71%) agreement was found when deciding to proceed with anticoagulation in non-liver transplant candidates with mesenteric vein thrombosis. Conclusions: While large-scale, methodologically rigorous randomized controlled trials are lacking to guide clinical decision making in patients with coagulation disorders and chronic liver disease, consensus expert opinion regarding mitigating peri-procedural bleeding risk and treatment of thrombosis appears consistent and strong.

UR - http://www.scopus.com/inward/record.url?scp=85074032741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074032741&partnerID=8YFLogxK

U2 - 10.1007/s10620-019-05884-0

DO - 10.1007/s10620-019-05884-0

M3 - Article

C2 - 31628574

AN - SCOPUS:85074032741

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

ER -